Close

Biogen (BIIB) Announces Receipt of Positive CHMP Opinion for TYSABRI in RRMS Patients

May 31, 2016 7:31 AM EDT Send to a Friend
The Committee of Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login